Prescriptions made by Michael John Pearce

Data for 2018

1,230

Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 55 providers in this state and specialty

$544.3K

Total Retail Price of All Prescriptions

Rank: 18 out of 55 providers in this state and specialty

154

Patients Receiving at Least One Drug in Part D

Rank: 12 out of 55 providers in this state and specialty

86%

Patients 65 Years and Older

73

Average Age of Patients

Average age of patients for providers in this state and specialty is 70

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Pulmonary Disease in Utah and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 MONTELUKAST SODIUM80
of 290
850 prescriptions
Less than 1% of all prescriptions
850190 patients
12% of all patients
190 patients
12% of all patients
2 ADVAIR DISKUS
(FLUTICASONE PROPION/SALMETEROL)
30
of 380
980 prescriptions
Less than 1% of all prescriptions
740200 patients
13% of all patients
< 11
3 SYMBICORT
(BUDESONIDE/FORMOTEROL FUMARATE)
80
of 370
790 prescriptions
Less than 1% of all prescriptions
590180 patients
12% of all patients
< 11
4 FLUTICASONE PROPIONATE60
of 250
480 prescriptions
Less than 1% of all prescriptions
200 patients
13% of all patients
< 11
5 PREDNISONE60
of 410
960 prescriptions
Less than 1% of all prescriptions
800350 patients
23% of all patients
< 11
6 SPIRIVA
(TIOTROPIUM BROMIDE)
40
of 290
540 prescriptions
Less than 1% of all prescriptions
540< 11< 11
7 PROAIR HFA
(ALBUTEROL SULFATE)
60
of 350
550 prescriptions
Less than 1% of all prescriptions
400220 patients
14% of all patients
< 11
8 OMEPRAZOLE140
of 280
340 prescriptions
Less than 1% of all prescriptions
< 11< 11
9 SPIRIVA RESPIMAT
(TIOTROPIUM BROMIDE)
90
of 240
370 prescriptions
Less than 1% of all prescriptions
150< 11< 11
10 VENTOLIN HFA
(ALBUTEROL SULFATE)
100
of 390
680 prescriptions
Less than 1% of all prescriptions
490320 patients
21% of all patients
< 11
11 BREO ELLIPTA
(FLUTICASONE/VILANTEROL)
120
of 230
330 prescriptions
Less than 1% of all prescriptions
330< 11< 11
12 XARELTO
(RIVAROXABAN)
30
of 60
300 prescriptions
Less than 1% of all prescriptions
< 11< 11
13 INCRUSE ELLIPTA
(UMECLIDINIUM BROMIDE)
30
of 220
410 prescriptions
Less than 1% of all prescriptions
210< 11< 11
14 FLOVENT HFA
(FLUTICASONE PROPIONATE)
20
of 110
400 prescriptions
Less than 1% of all prescriptions
400< 11< 11
15 DULERA
(MOMETASONE/FORMOTEROL)
40
of 130
290 prescriptions
Less than 1% of all prescriptions
290< 11< 11
16 PANTOPRAZOLE SODIUM60
of 100
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
17 DALIRESP
(ROFLUMILAST)
30
of 110
260 prescriptions
Less than 1% of all prescriptions
260< 11< 11
18 ROPINIROLE HCL30
of 50
140 prescriptions
Less than 1% of all prescriptions
140< 11< 11
19 NYSTATIN10
of 60
280 prescriptions
Less than 1% of all prescriptions
< 11< 11
20 LETAIRIS
(AMBRISENTAN)
70
of 90
130 prescriptions
Less than 1% of all prescriptions
130< 11< 11
21 ADEMPAS
(RIOCIGUAT)
50
of 60
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
22 FLOVENT DISKUS
(FLUTICASONE PROPIONATE)
40
of 50
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
23 MODAFINIL40
of 40
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
24 AZITHROMYCIN160
of 320
280 prescriptions
Less than 1% of all prescriptions
160 patients
10% of all patients
< 11A